The company said in a state Worker Adjustment and Retraining Notification note Nov. 8 that it will cut 149 people at its research facility in Kendall Square. The move comes just a few years after the company expanded to New England from its headquarters in Thousand Oaks, Calif.
Amgen will consolidate the rest of its U.S.-based research work at its Thousand Oaks headquarters and San Francisco offices. A spokesperson did not immediately say what would happen to the rest of the Cambridge-based employees, according to the Boston Business Journal.
The decision comes around the same time the company acquired a 20 percent stake in Chinese drugmaker BeiGene for $2.7 billion.
Read the full article here.
More articles on pharmacy:
Endo CEO to retire
Trump administration sues Gilead
CVS to close 22 ‘underperforming’ stores
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
